Pathstone Holdings
IDXX icon

Pathstone Holdings’s Idexx Laboratories IDXX Stock Holding History

Pathstone Holdings’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
20,623
+1,129
+6% +$633K 0.03% 376
2026
Q1 		$11M Buy
19,494
+691
+4% +$443K 0.04% 317
2025
Q4 		$12.7M Sell
18,803
-1,031
-5% -$702K 0.05% 260
2025
Q3 		$12.7M Buy
19,834
+350
+2% +$212K 0.05% 268
2025
Q2 		$10.5M Sell
19,484
-1,883
-9% -$900K 0.04% 313
2025
Q1 		$8.98M Buy
21,367
+311
+1% +$135K 0.04% 375
2024
Q4 		$8.71M Sell
21,056
-2,604
-11% -$1.14M 0.04% 360
2024
Q3 		$12M Sell
23,660
-1,440
-6% -$700K 0.05% 268
2024
Q2 		$12.2M Buy
25,100
+69
+0.3% +$34.6K 0.06% 256
2024
Q1 		$13.5M Buy
25,031
+7,612
+44% +$4.16M 0.06% 229
2023
Q4 		$9.67M Buy
+17,419
New +$8.18M 0.05% 263

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Pathstone Holdings's IDXX Position: Q2 2026 in Review

Pathstone Holdings increased its Idexx Laboratories (IDXX) stake by 5.8% in Q2 2026, buying an estimated $633K and bringing the position to 20,623 shares worth $10.9M. The position accounts for 0.03% of the portfolio, ranked #376.

Pathstone Holdings first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.5M in Q1 2024. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Pathstone Holdings held 20,623 shares of Idexx Laboratories worth $10.9M as of Q2 2026.
  • Pathstone Holdings bought 1,129 Idexx Laboratories shares in Q2 2026, an estimated $633K.
  • Idexx Laboratories made up 0.03% of Pathstone Holdings's portfolio in Q2 2026, its #376 holding.
  • Pathstone Holdings first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Idexx Laboratories position peaked at $13.5M in Q1 2024.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.